COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,870 Articles (22,568 medRxiv, 8,302 bioRxiv)

Most recent first Previous |  Page 2502: Articles 25011-25020  | Next

Electrocardiographic safety of daily Hydroxychloroquine 400mg plus Azithromycin 250mg as an ambulatory treatment for COVID-19 patients in Cameroon.
Mfeukeu Kuate, L., Ngatchou, W., Temgoua, M. N., Kouanfack, C., Lemogoum, D., Noutakdie Tochie, J., Zemsi, A., Fomete, L., Lekelem, S., Zemsi, S., Tambekou Sobngwi, J., Ntandzi, T., Ngongang Ouankou, C., Wasnyo, Y., Ntsama Assiga, A., Nkeck, J. R., Musa Jingi, A., Guewo, M., Pefura Yone, E. W., Omgba Moussi, C., Owono Etoundi, P., Yombi, J. C., Menanga, A. P., Kingue, S., Ze Minkande, J., Mbanya, J. C., Ongolo Zogo, P. C., Fouda, P. J., Sobngwi, E.
10.1101/2020.06.24.20139386 — Posted: 2020-06-29
SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission
Fontanet, A., Grant, R., Tondeur, L., Madec, Y., Grzelak, L., Cailleau, I., Ungeheuer, M.-N., Renaudat, C., Fernandes Pellerin, S., Kuhmel, L., Staropoli, I., Anna, F., Charneau, P., Demeret, C., Bruel, T., Schwartz, O., Hoen, B.
10.1101/2020.06.25.20140178 — Posted: 2020-06-29 Discussion: Onsite | Offsite
Blood parameters measured on admission as predictors of outcome for COVID-19; a prospective UK cohort study
Arnold, D. T., Attwood, M., Barratt, S., Elvers, K., Morley, A., McKernon, J., Oates, A., Donald, C., Noel, A., MacGowan, A., Maskell, N. A., Hamilton, F.
10.1101/2020.06.25.20137935 — Posted: 2020-06-29
Face Masks Considerably Reduce Covid-19 Cases in Germany
Mitze, T., Kosfeld, R., Rode, J., Wälde, K.
10.1101/2020.06.21.20128181 — Posted: 2020-06-29
Assessment of the use and quick preparation of saliva for rapid microbiological diagnosis of COVID-19.
Vila, J., Fernandez-Pittol, M., Hurtado, J. C., Moreno-Garcia, E., Rubio Garcia, E., Navarro, M., Valiente, M., Peiro, A., Seijas, N., Capon, A., Martinez, M. J., Casals-Pascual, C.
10.1101/2020.06.25.172734 — Posted: 2020-06-29
A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture
Shema Mugisha, C., Vuong, H. R., Puray-Chavez, M., Kutluay, S. B.
10.1101/2020.06.26.174698 — Posted: 2020-06-28
Integrate Structural Analysis, Isoform Diversity, and Interferon-Inductive Propensity of ACE2 to Refine SARS-CoV2 Susceptibility Prediction in Vertebrates
Sang, E. R., Tian, Y., Gong, Y., Miller, L. C., Sang, Y.
10.1101/2020.06.27.174961 — Posted: 2020-06-28
Predicting the Trajectory of Any COVID19 Epidemic From the Best Straight Line
Levitt, M., Scaiewicz, A., Zonta, F.
10.1101/2020.06.26.20140814 — Posted: 2020-06-28 Discussion: Onsite
Prevalence of SARS-CoV-2 among workers returning to Bihar gives snapshot of COVID across India
Malani, A., Mohanan, M., Kumar, C., Kramer, J., Tandel, V.
10.1101/2020.06.26.20138545 — Posted: 2020-06-28
Problem drinking before and during the COVID-19 crisis in US and UK adults: Evidence from two population-based longitudinal studies
Daly, M., Robinson, E.
10.1101/2020.06.25.20139022 — Posted: 2020-06-28

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).